Sungmin Zo

Sungmin Zo

Auto-generated profile, based on publicly available information

Sungmin Zo

Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
HGHyun-Il Gil
Hyun-Il Gil
SZSungmin Zo
Sungmin Zo
PJPaul W Jones
Paul W Jones
BKBo-Guen Kim
Bo-Guen Kim
NKNoeul Kang
Noeul Kang
SSSun Hye Shin
Sun Hye Shin
Purpose: The chronic obstructive pulmonary disease (COPD) assessment test (CAT) is widely used to assess the impact of COPD symptoms on health status. Whilst the CAT consists of eight different items, details on the distribution of each item are limited. This study aimed to investigate the distribution and clinical implication of each CAT item, stratified by CAT severity group, in stable COPD patients. Patients and Methods: This was a cross-sectional study at a single referral hospital in South Korea. Spirometry confirmed COPD patients with CAT measured at the first clinical visit were retrospectively identified. Patients were categorized into three groups: low (0 ≤ CAT < 10), medium (10 ≤ CAT < 20), and high (20 ≤ CAT ≤ 40) impact group. For the purpose of this analysis, the first four items (cough, sputum, chest tightness, and dyspnea) and the remaining four items (activities, confidence, sleep and energy) were also grouped as “pulmonary” and “extra-pulmonary”, respectively. Results: A total of 815 patients were included, and mean (SD) forced expiratory volume in 1 s (FEV1) was 62.8 (17.4) % pred. Among them, 300 patients (36.8%) were in the high impact group and had a greater exacerbation history and lower lung function. The proportion of “extra-pulmonary” items score was greater in patients with higher total CAT scores, with the activity and confidence items showing higher scores. Conclusion: In our study, in addition to dyspnea, activity limitation is a particular problem in individual patients with higher CAT total scores, for which physicians need to pay more attention. Our study suggests that whilst CAT total score captures the overall impact of COPD, each item of the CAT contains potentially useful information in understanding the patient’s symptom burden.

13 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SZSungmin Zo
Sungmin Zo
SWSook-Young Woo
Sook-Young Woo
SKSeonwoo Kim
Seonwoo Kim
JLJung Eun Lee
Jung Eun Lee
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
Kyungjong LeeKyungjong Lee
Kyungjong Lee
The next diagnostic step in cases of indeterminate radial probe endobronchial ultrasound (radial EBUS)-guided biopsy results remains uncertain. This study aimed to identify risk factors for malignancy based on clinical findings, chest computed tomography (CT), and radial EBUS images, and to estimate the risk of malignancy in lung nodules that showed indeterminate radial EBUS-guided biopsy results by constructing a nomogram. This retrospective study included 157 patients with indeterminate results on an initial radial EBUS biopsy performed at the Samsung Medical Center from January 2017 to December 2018, but with a definitive final diagnosis. Medical records, chest CT, radial EBUS images, and the final diagnoses were reviewed. Patients were randomly divided into training and validation sets. Factors related to malignancy were identified through logistic regression analysis, and a nomogram was constructed using the training set and subsequently applied to the validation set. Six factors in univariable and multivariable analyses, including upper lobe location, spiculation, satellite nodules, echogenicity, presence of dots or linear arcs, and patency of vessels and bronchi predicted malignancy. A nomogram was constructed based on these predictors. The area under the curve (AUC) value of the nomogram was 0.858 using the chest CT factors, which improved to 0.952 when radial EBUS factors were added. The calibration curve showed good agreement between the actual and nomogram-predicted malignancy outcomes. The utility of radial EBUS images for revealing risk factors of malignancy was confirmed. Furthermore, our nomogram was able to predict the probability of malignancy in lung nodules with indeterminate radial EBUS-guided biopsy results.

1 October 2024 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
SZSungmin Zo
Sungmin Zo
JMJi-Yong MOON
Ji-Yong MOON
KMKyung Hoon Min
Kyung Hoon Min
Hyun LeeHyun Lee
Hyun Lee
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing bronchiectasis is to identify the underlying cause. Immunodeficiency is a rare but important cause of bronchiectasis, and its treatability is a significant trait for bronchiectasis management. While primary immunodeficiencies in bronchiectasis are well recognized, secondary immunodeficiencies remain under-reported and under-researched. Secondary immunodeficiencies may result from various diseases and conditions, such as hematologic malignancies, human immunodeficiency virus infection, renal transplantation, or the use of immunosuppressive drugs, and may contribute to the occurrence of bronchiectasis. Recurrent pulmonary and/or extrapulmonary infections in bronchiectasis may indicate the presence of secondary immunodeficiency in patients with these underlying conditions. For treatment, examining the underlying condition, managing bronchiectasis adequately, and prophylactic antibiotics (e.g., macrolide) and/or supplementary immunoglobulin G therapy may provide potential benefits. Considering the projected increase in the prevalence of secondary immunodeficiencies and bronchiectasis, future guidelines and research on the diagnosis and optimized treatment are needed.

4 September 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
DKDae Hun Kim
Dae Hun Kim
SZSungmin Zo
Sungmin Zo
SKSu-Young Kim
Su-Young Kim
BJByung Woo Jhun
Byung Woo Jhun
Dae Hun Kim, Ph.D.*, Sungmin Zo, M.D.*, Su-Young Kim, Ph.D., and Byung Woo Jhun, M.D., Ph.D.. Ann Lab Med 2024;44:92-6. https://doi.org/10.3343/alm.2024.44.1.92

1 January 2023 in Therapeutic Advances in Respiratory Disease
Verified
Journal Article
Open access
SZSungmin Zo
Sungmin Zo
MCMan Pyo Chung
Man Pyo Chung
HYHak Young Yoo
Hak Young Yoo
KLKyung Soo Lee
Kyung Soo Lee
JHJoungho Han
Joungho Han
HYHongseok Yoo
Hongseok Yoo
Background: Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) that results from an immune-mediated reaction involving various antigens in susceptible individuals. However, the clinical characteristics and outcomes of HP in South Korea are not well understood. Objectives: This study was conducted to identify the clinical characteristics and outcomes of HP in South Korea. Design: This is a retrospective observational study investigating patients with pathologically confirmed HP at our center, along with a comprehensive review of published HP cases in the Republic of Korea. Methods: This retrospective study analyzed 43 patients with pathologically proven HP at a single tertiary hospital in Korea between 1996 and 2020. In addition, case reports of HP published in Korea were collected. The clinical characteristics, etiologies, treatment, and outcomes of patients from our center, as well as case reports, were reviewed. Patients from our hospital were divided into fibrotic and nonfibrotic subtypes according to the ATS/JRS/ALAT guidelines. Results: Among 43 patients with biopsy-proven HP, 12 (27.9%) and 31 (72.1%) patients were classified into the fibrotic and nonfibrotic subtypes, respectively. The fibrotic HP group was older (64.6 ± 8.5 versus 55.2 ± 8.3, p = 0.002) with less frequent complaints of fever (0% versus 45.2%, p = 0.013) compared to the nonfibrotic HP group. The most common inciting antigen was household mold (21, 48.8%), followed by inorganic substances (6, 14.0%). Inciting antigens were not identified in eight (18.6%) patients. Treatment of corticosteroids was initiated in 34 (79.1%) patients. An analysis of 46 patients from Korea by literature review demonstrated that reported cases were relatively younger and drugs were the most common etiology compared to our cohort. Conclusion: The analysis of reported cases, as well as our cohort, showed that exposure history and clinical manifestations are heterogeneous for patients with HP in South Korea.

1 January 2025 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
SZSungmin Zo
Sungmin Zo
Hyun LeeHyun Lee
Hyun Lee
CJCho Yun Jeong
Cho Yun Jeong
BKBo-Guen Kim
Bo-Guen Kim
JCJee Eun Chung
Jee Eun Chung
SKSang-Heon Kim
Sang-Heon Kim
Zo S, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):135-146. https://doi.org/10.4168/aair.2025.17.1.135